Pathophysiology of Anemias and Hematologic Disorders

In more severe cases, the problem lies within the bone marrow itself. Aplastic Anemia is characterized by bone marrow failure, leading to pancytopenia—a simultaneous decrease in RBCs, white blood cells (WBCs), and platelets. This creates a high-risk profile for patients: low WBCs increase infection risk, while low platelets increase bleeding risk.

Hemolytic and Chronic Anemias

Hemolytic Anemia occurs when RBCs are destroyed prematurely. This rapid destruction often leads to jaundice and gallstones due to the release of hemoglobin components. Similarly, Chronic Disease Anemia is driven by underlying inflammation or chronic illness that interferes with normal RBC production.

Sickle Cell Anemia (SCA)

Sickle Cell Anemia is a complex autosomal recessive genetic disorder. The pathophysiology involves a single point mutation where valine replaces glutamic acid in the beta chain of hemoglobin, creating Hemoglobin S (HbS).

Under physiological stress—specifically hypoxia, dehydration, or infection—the HbS molecules cause the RBCs to become rigid and assume a sickle shape. This leads to two primary complications:

1. Vaso-occlusion: The rigid cells block small vessels, causing ischemia, severe pain (vaso-occlusive crisis), and organ damage.
2. Hemolysis: The fragile sickle cells break down early, causing chronic anemia and jaundice.

Exam Tip: The "HOP" Management for SCA When managing a sickle cell crisis, remember HOP: Hydration, Oxygen, and Pain control. Hydroxyurea is also a key pharmacological intervention.

Coagulation and Vascular Disorders

While anemias involve the cells themselves, other hematologic disorders involve the blood's ability to clot or the health of the vessels they travel through.

Hemophilia

Hemophilia is an X-linked genetic disorder, meaning it primarily affects males. It is characterized by deficiencies in specific clotting factors:

• Hemophilia A: Deficiency in Factor VIII.
• Hemophilia B: Deficiency in Factor IX.
• Hemophilia C: Deficiency in Factor XI.

A hallmark clinical sign of hemophilia is hemarthrosis (bleeding into the joints). Management involves factor replacement therapy and strict education: patients should use acetaminophen for pain, but must avoid NSAIDs (like ibuprofen or aspirin) because they interfere with platelet function and increase bleeding risk.

Thrombosis and Embolism

A thrombus is a blood clot that remains attached to a vessel wall, whereas an embolus is a piece of a clot that breaks loose and travels through the bloodstream. The formation of these clots is often driven by the Virchow Triad: stasis (slow blood flow), vessel injury, and hypercoagulability.

• Deep Vein Thrombosis (DVT): Typically presents as unilateral swelling, warmth, and redness in a limb (often the calf).
• Pulmonary Embolism (PE): A life-threatening emergency that occurs when an embolus travels to the lungs. Symptoms include sudden dyspnea (shortness of breath), chest pain, tachycardia, and anxiety.
• Arterial Clots: These can lead to acute ischemia. Clinicians look for the "6 Ps": pain, pallor, pulselessness, paresthesia, paralysis, and poikilothermia (coldness).

Venous Insufficiency and Varicose Veins

Chronic Venous Insufficiency occurs when the veins have difficulty sending blood from the limbs back to the heart. This leads to poor circulation and increased pressure in the veins, resulting in:

• Varicose Veins: Swollen, twisted veins caused by weakened vessel walls.
• Venous Stasis Ulcers: Skin breakdown caused by impaired tissue perfusion.

Management focuses on improving venous return through leg elevation (above the heart) and the use of compression stockings.

Clinical Note: Compression Stockings When applying anti-embolic stockings, ensure there are no wrinkles, as these can cause skin breakdown. They should be applied in the morning before getting out of bed and removed daily for skin inspection.